Galantamine and carbon monoxide protect brain microvascular endothelial cells by heme oxygenase-1 induction

Biochemical and Biophysical Research Communications

Volumn 367, Issue 3, 2008, Pages 674-679

  Nakao, Atsunori ^a   Kaczorowski, David J ^a   Zuckerbraun, Brian S ^a   Lei, Jing ^a   Faleo, Gaetano ^a   Deguchi, Kentaro ^b   McCurry, Kenneth R ^a   Billiar, Timothy R ^a   Kanno, Shinichi ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; Carbon monoxide; Galantamine; Heme oxygenase; Inducible nitric oxide synthase; Nuclear factor B; Vascular dementia; Vascular endothelial cells

Indexed keywords

CARBON MONOXIDE; DONEPEZIL; GALANTAMINE; HEME OXYGENASE 1; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; BRAIN PROTECTION; CELL PROTECTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERTENSION; MICROVASCULATURE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SKIN CELL; WESTERN BLOTTING;

ANIMALS; BETA-GALACTOSIDASE; BRAIN; CARBON MONOXIDE; CELL DEATH; CELLS, CULTURED; CYTOPROTECTION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; ENZYME INDUCTION; ENZYME INHIBITORS; GALANTAMINE; GENE TRANSFER TECHNIQUES; HEME OXYGENASE-1; HUMANS; HYDROGEN PEROXIDE; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OXIDANTS; OXIDATIVE STRESS; RATS; RATS, INBRED SHR;

RATTUS;

EID: 38649131957     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.152     Document Type: Article

References (28)

1. Schrattenholz A., Pereira E.F., Roth U., Weber K.H., Albuquerque E.X., and Maelicke A. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol. Pharmacol. 49 (1996) 1-6
2. Scott L.J., and Goa K.L. Galantamine: a review of its use in Alzheimer's disease. Drugs 60 (2000) 095-1122
3. Woodruff-Pak D.S., Vogel III R.W., and Wenk G.L. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc. Natl. Acad. Sci. USA 98 (2001) 2089-2094
4. de la Torre J.C., and Stefano G.B. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res. Brain Res. Rev. 34 (2000) 119-136
5. Maelicke A. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl). Int. J. Clin. Pract. Suppl. 120 (2001) 24-28
6. Samochocki M., Zerlin M., Jostock R., Groot Kormelink P.J., Luyten W.H., Albuquerque E.X., and Maelicke A. Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR. Acta Neurol. Scand. Suppl. 176 (2000) 68-73
7. Kurz A.F., Erkinjuntti T., Small G.W., Lilienfeld S., and Damaraju C.R. Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease. Eur. J. Neurol. 10 (2003) 633-640
8. Wilcock G., Howe I., Coles H., Lilienfeld S., Truyen L., Zhu Y., Bullock R., and Kershaw P. A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease. Drugs. Aging 20 (2003) 777-789
9. Ancoli-Israel S., Amatniek J., Ascher S., Sadik K., and Ramaswamy K. Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study. Alzheimer. Dis. Assoc. Disord. 19 (2005) 240-245
10. Chen K., Gunter K., and Maines M.D. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J. Neurochem. 75 (2000) 304-313
11. Rossler O.G., Bauer I., Chung H.Y., and Thiel G. Glutamate-induced cell death of immortalized murine hippocampal neurons: neuroprotective activity of heme oxygenase-1, heat shock protein 70, and sodium selenite. Neurosci. Lett. 362 (2004) 253-257
12. Bresgen N., Karlhuber G., Krizbai I., Bauer H., Bauer H.C., and Eckl P.M. Oxidative stress in cultured cerebral endothelial cells induces chromosomal aberrations, micronuclei, and apoptosis. J. Neurosci. Res. 72 (2003) 327-333
13. Parfenova H., Fedinec A., and Leffler C.W. Ionotropic glutamate receptors in cerebral microvascular endothelium are functionally linked to heme oxygenase. J. Cereb. Blood Flow. Metab. 23 (2003) 190-197
14. Calabrese V., Butterfield D.A., and Stella A.M. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease. Ital. J. Biochem. 52 (2003) 177-181
15. Sabbatini M., Catalani A., Consoli C., Marletta N., Tomassoni D., and Avola R. The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia?. Mech. Ageing Dev. 123 (2002) 547-559
16. 2 in newborn pig brain microvascular endothelial cells. Am. J. Physiol. 264 (1993) H1485-H1492
17. Taylor B.S., de Vera M.E., Ganster R.W., Wang Q., Shapiro R.A., Morris Jr. S.M., Billiar T.R., and Geller D.A. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273 (1998) 15148-15156
18. Brouard S., Berberat P.O., Tobiasch E., Seldon M.P., Bach F.H., and Soares M.P. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J. Biol. Chem. 277 (2002) 17950-17961
19. Zuckerbraun B.S., Billiar T.R., Otterbein S.L., Kim P.K., Liu F., Choi A.M., Bach F.H., and Otterbein L.E. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J. Exp. Med. 198 (2003) 1707-1716
20. Black S., Roman G.C., Geldmacher D.S., Salloway S., Hecker J., Burns A., Perdomo C., Kumar D., and Pratt R. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 34 (2003) 2323-2330
21. Winblad B., Kilander L., Eriksson S., Minthon L., Batsman S., Wetterholm A.L., Jansson-Blixt C., and Haglund A. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Lancet 367 (2006) 1057-1065
22. Arias E., Gallego-Sandin S., Villarroya M., Garcia A.G., and Lopez M.G. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J. Pharmacol. Exp. Ther. 315 (2005) 1346-1353
23. Pachori A.S., Smith A., McDonald P., Zhang L., Dzau V.J., and Melo L.G. Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J. Mol. Cell. Cardiol. 43 (2007) 580-592
24. Dajas-Bailador F.A., Lima P.A., and Wonnacott S. The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca (2+) dependent mechanism. Neuropharmacology 39 (2000) 2799-2807
25. Fernandez M., and Bonkovsky H.L. Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane. Br. J. Pharmacol. 139 (2003) 634-640
26. Hegazi R.A., Rao K.N., Mayle A., Sepulveda A.R., Otterbein L.E., and Plevy S.E. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J. Exp. Med. 202 (2005) 1703-1713
27. Swerlick R.A., and Lawley T.J. Role of microvascular endothelial cells in inflammation. J. Invest. Dermatol. 100 (1993) 111S-115S
28. Page C., Rose M., Yacoub M., and Pigott R. Antigenic heterogeneity of vascular endothelium. Am. J. Pathol. 141 (1992) 673-683